This announcement is a separate document:
亚太药业：北京国枫（杭州）律师事务所关于浙江亚太药业股份有限公司 2024 年第二次临时股东大会的法律意见书
Asia Pacific Pharmaceutical: Legal Opinion of Beijing Guofeng (Hangzhou) Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Zhejiang Asia Pacific Pharmaceutical Co., Ltd.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated